Do you want to read an article? Please log in or register.
Occurrence of skin manifestations in patients of the Swiss Inflammatory Bowel Disease Cohort Study
Inflammatory Bowel Disease
Related content
RECOMMENDED
Inflammatory Bowel Disease
Uveitis manifestations in patients of the Swiss Inflammatory Bowel Disease Cohort Study
Therap Adv Gastroenterol.
Biedermann L, Renz L, Fournier N, Rossel JB, Butter M, Bluemel S, Vavricka SR, Rogler G, Scharl M
doi: 10.1177/1756284819865142.
Inflammatory Bowel Disease
Effect of distance to specialist care for the diagnosis and disease outcome of inflammatory bowel disease in the Swiss inflammatory bowel disease cohort study
Therap Adv Gastroenterol.
Grob L, Bluemel S, Biedermann L, Fournier N, Rossel JB, Vavricka SR, Zeitz J, Rogler G, Stallmach A, Scharl M
doi: 10.1177/1756284819895217.
Gastrointestinal DiseasesInflammatory Bowel Disease
The impact of colectomy on the course of extraintestinal manifestations in Swiss inflammatory bowel disease cohort study patients
United European Gastroenterol J
Roth R, Vavricka S, Scharl M, Schreiner P, Safroneeva E, Greuter T, Zeitz J, Misselwitz B, Schoepfer A, Barry MP, Rogler G, Biedermann L, Swiss IBD cohort study.
doi: 10.1002/ueg2.12125
Inflammatory Bowel Disease
The Relevance of Vitamin and Iron Deficiency in Patients with Inflammatory Bowel Diseases in Patients of the Swiss IBD Cohort
Inflamm Bowel Dis.
Madanchi M, Fagagnini S, Fournier N, Biedermann L, Zeitz J, Battegay E, Zimmerli L, Vavricka SR, Rogler G, Scharl M; Swiss IBD Cohort Study Group.
doi: 10.1093/ibd/izy054.
Inflammatory Bowel Disease
Frequency and type of drug-related side effects necessitating treatment discontinuation in the Swiss Inflammatory Bowel Disease Cohort
Eur J Gastroenterol Hepatol.
Godat S, Fournier N, Safroneeva E, Juillerat P, Nydegger A, Straumann A, Vavricka S, Biedermann L, Greuter T, Fraga M, Abdelrahman K, Hahnloser D, Sauter B, Rogler G, Michetti P, Schoepfer AM, Swiss IBD Cohort Study Group
doi: 10.1097/MEG.
Inflammatory Bowel Disease
Illness Perception in Inflammatory Bowel Disease Patients is Different Between Patients With Active Disease or in Remission: A Prospective Cohort Study
doi: 10.1093/ecco-jcc/jjy183.
Inflammatory Bowel Disease
Malignancies in Inflammatory Bowel Disease: Frequency, Incidence and Risk Factors-Results from the Swiss IBD Cohort Study
Am J Gastroenterol.
Scharl S, Barthel C, Rossel JB, Biedermann L, Misselwitz B, Schoepfer AM, Straumann A, Vavricka SR, Rogler G, Scharl M, Greuter T
doi: 10.1038/s41395-018-0360-9.
COMMENTED
Inflammatory Bowel Disease
Impact of obesity on disease activity and disease outcome in inflammatory bowel disease: Results from the Swiss inflammatory bowel disease cohort
★ 1
Recommended and commented by
Prof. Dr Stephan Vavricka, Faculty Member
United European Gastroenterol J
Greuter T, Porchet F, Braga-Neto MB, Rossel JB, Biedermann L, Schreiner P, Scharl M, Schoepfer AM, Safroneeva E, Straumann A, Rogler G, Vavricka SR
doi: 10.1177/2050640620954556
RECOMMENDED
Inflammatory Bowel Disease
Disease course of inflammatory bowel disease unclassified in a European population-based inception cohort - an Epi-IBD study
doi: 10.1111/jgh.14563.